Evotec and Celgene Corp. have entered into a third strategic drug discovery and development partnership in the field of targeted protein degradation. In this collaboration, the companies will leverage Evotec’s Panomics platform to identify drug targets that are traditionally difficult to track. Evotec’s Panomics platform applies high-end proteomics and transcriptomics at industrial scale to profile and select promising drug candidates on the basis of comprehensive cell biological ...